Multiple Sclerosis

• Author : Neil Scolding,Alastair Wilkins
• Publisher : Oxford University Press, USA
• Release : 05 July 2012

Part of the Oxford Neurology Library series, this practical pocketbook will summarise the latest understanding of what might cause the disease, the methods of diagnosis and assessment, and current management techniques.

• Author : Anonim
• Publisher : Unknown
• Release : 11 August 2022

• Author : J. F. Hallpike,Colin Wallace Maitland Adams,Wallace W. Tourtellotte
• Publisher : Unknown
• Release : 11 August 1983

• Author : Claudia Lucchinetti,Reinhard Hohlfeld
• Publisher : Elsevier Health Sciences
• Release : 29 October 2009

Multiple Sclerosis 3 emphasizes the latest in the pharmacologic treatment of this incurable inflammatory demyelinating disorder. Primary editors Claudia Lucchinetti, MD, and Reinhard Hohlfeld, MD, with the aid of all new contributors, present a complete and current reference on multiple sclerosis that includes discussions of such hot topics as Biomarkers, Genomics, and Surrogate Outcomes in MS; Pediatric MS; Transverse Myelitis; Attack Therapies in MS; Current Disease-Modifying Therapeutic Strategies in MS; Management of Aggressive MS; Symptomatic Therapies in MS; Complementary and Alternative

• Author : June Halper,Colleen Harris
• Publisher : Springer Publishing Company
• Release : 22 November 2011

Print+CourseSmart

• Author : U. Utz
• Publisher : IOS Press
• Release : 01 November 2006

"Several processes are presumed to sequentially or simultaneously contribute to the pathophysiology of multiple sclerosis (MS). Biomarkers indicative of these processes would hold great potential for (1) MS diagnostics and identification of disease stages and subcategories; (2) prediction of onset and disease course; (3) treatment selection and improved prognosis of treatment success; and (4) the evaluation of novel therapeutics. Though it is unlikely that any one marker could function as a true surrogate or stand alone, biomarker combinations or patterns could provide insight into

• Author : Stuart D. Cook
• Publisher : CRC Press
• Release : 30 March 2001

Reporting on the latest advances made in treating multiple sclerosis (MS) and continuing the high standards set by earlier editions, the Handbook of Multiple Sclerosis, Third Edition examines a wide range of topics from etiology to treatment options. Analyzes recent developments in the natural history, immunopathology, lesion evolution, and

• Author : Douglas McAlpine,Alastair Compston
• Publisher : Elsevier Health Sciences
• Release : 11 August 2022

Comprehensive text highlighting current clinical research in the area of multiple sclerosis. Includes expanded coverage of genetics, neurobiology, pathophysiology, and historical background.

• Author : Irene Håkansson
• Publisher : Linköping University Electronic Press
• Release : 07 October 2019

This thesis focuses on disease activity in clinically isolated syndrome (CIS) and newly diagnosed relapsing remitting multiple sclerosis (RRMS). The papers are based on data from 41 patients in a prospective longitudinal cohort study. All patients were untreated at baseline. Age- and sex-matched healthy controls (n=22) for blood and cerebrospinal fluid (CSF) samples were recruited from blood donors. Paper I evaluated the prognostic value of baseline levels of CXCL1, CXCL8, CXCL10, CXCL13, CCL22, neurofilament light chain (NFL), neurofilament heavy chain, glial

• Author : George Jelinek
• Publisher : ReadHowYouWant.com
• Release : 19 October 2010

Large Print.

• Author : Ehud Lavi,Cris S. Constantinescu
• Publisher : Springer Science & Business Media
• Release : 03 January 2008

Multiple Sclerosis (MS) is an enigmatic immune mediated disease of the central nervous system that affects about 350,000 individuals in the US, and many more around the world. The mechanism of this disease is largely unknown and there is no cure for it. However, there are several well-characterized experimental animal models that help us understand and speculate about potential mechanisms of pathology in this disease. Many of the experimental therapies designed for this disease rely on testing the drugs in animal

• Author : Lorraine De Souza,Action and Research for Multiple Sclerosis
• Publisher : Springer
• Release : 14 December 2013

• Author : Anonim
• Publisher : Unknown
• Release : 11 August 2022

• Author : Ana Martinez
• Publisher : Royal Society of Chemistry
• Release : 18 June 2019

Multiple sclerosis (MS) is a complex disease with a presumed autoimmune aetiology and few current effective treatments. Disease modifying therapies focus on the altering the natural course of relapsing and remitting MS, targeting the inflammatory response. Other targets involve tacking the cause of the disease – demyelination of axons through remyelination therapies. Due to several recent breakthroughs in the understanding of the pathophysiology of MS new targets for remyelination and immunomodulation are rapidly emerging. This book provides a comprehensive overview of

• Author : Barbara S. Giesser
• Publisher : Oxford University Press
• Release : 11 February 2016

Primer on Multiple Sclerosis, 2nd Edition is an updated reference manual for the practicing clinician. It covers the range of information needed to treat persons with MS, beginning with basic science and immunopathology, thorough differential diagnosis, symptom management and disease modifying therapies. This essential book also includes material covering new and experimental strategies as well as a review of commonly used complementary and alternative modalities that are used by persons with MS.Multiple Sclerosis (MS) is the most common demyelinating